Covington Reps Forest Labs In $1.2B Clinical Data Deal
Forest Laboratories Inc. announced Tuesday that it would purchase Clinical Data Inc. for $1.2 billion, aiming to add Clinical Data's newly approved drug Viibryd to its portfolio of blockbuster antidepressants....To view the full article, register now.
Already a subscriber? Click here to view full article